Diligence memo · auto-generated · as of July 2, 2026
Par Health, Inc.
Par Health, Inc. has raised $763M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Par Health, Inc. operates in Pharmaceuticals, based in St. Louis. Learn how Par Health’s legacy, values, and people shape a culture of excellence, integrity and unwavering dedication to those we serve.
Sub-sector tags: pharma.
Capital & rounds (filed)filed
Par Health, Inc. has raised $763M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Growth/Late (a round over $400M).
Largest single filing: $763M on 2025-11-10.
Most recent recorded round closed around 2025-11-10.
Valuation (modeled)modeled
Provath models Par Health, Inc. at approximately $6.8B (range $5.0B–$7.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 8 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 100% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: Immunovant, Inc..
Peoplefiled
14 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.